sirolimus
RxNorm 35302· ATC L01EG04
KR · 한국Products in Korea (12)
- 라파로벨정2밀리그램(시롤리무스)(주)종근당
- 라파로벨정2밀리그램(시롤리무스)(주)종근당
- 라파로벨정1밀리그램(시롤리무스)(주)종근당
- 라파로벨정1밀리그램(시롤리무스)(주)종근당
- 라파로벨정0.5밀리그램(시롤리무스)(주)종근당
- 라파로벨정0.5밀리그램(시롤리무스)(주)종근당
- 라파뮨정1밀리그램(시롤리무스)한국화이자제약(주)
- 라파뮨정1밀리그램(시롤리무스)한국화이자제약(주)
- 라파뮨정2밀리그램(시롤리무스)한국화이자제약(주)
- 라파뮨정2밀리그램(시롤리무스)한국화이자제약(주)
- 라파뮨정0.5밀리그램(시롤리무스)한국화이자제약(주)
- 라파뮨정0.5밀리그램(시롤리무스)한국화이자제약(주)
U.S. drug label (openFDA)
FYARRO — indications, dosage, warnings, adverse events →Chemistry (PubChem)
- Molecular formula
- C51H79NO13
- Molecular weight
- 914.2 g/mol
- IUPAC name
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- InChIKey
- QFJCIRLUMZQUOT-HPLJOQBZSA-N